- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
草酸艾司西酞普兰加心理干预对老年冠心病并发抑郁症的疗效分析
[摘要] 目的 观察草酸艾司西酞普兰加心理干预治疗老年冠心病并发抑郁症患者的效果。 方法 冠心病伴发抑郁障碍患者54例,将其分为治疗组(30例)与对照组(24例)。治疗组给予草酸艾司西酞普兰治疗和心理干预,起始剂量5 mg/d,最高日剂量为20 mg,总疗程为6周;对照组采用常规药物治疗。治疗6周评定疗效,同时观察不良反应。 结果 治疗组患者6周后焦虑自评量表、抑郁自评量表、汉密顿抑郁量表评分、抑郁情绪改善程度和同型半胱氨酸、超敏C反应蛋白下降程度、临床总有效率均优于对照组(P 0.01或P 0.05)。 结论 草酸艾司西酞普兰治疗加上心理干预对冠心病抑郁症患者疗效好,且起效快,副作用少,安全性高。
[关键词] 草酸艾司西酞普兰;老年;冠心病;抑郁症;心理干预
[中图分类号] R543.3 [文献标识码] A [文章编号] 1673-7210(2014)02(b)-0072-03
The curative effect analysis to treat depressive disorder in elderly coronary heart disease with Escitalopram Oxalate and psychological intervention
LU Xiongsheng
Department of Geriatrics, the Second People′s Hospital of Lishui City, Zhejiang Province, Lishui 323000, China
[Abstract] Objective To observe and analyze the curative effect of Escitalopram Oxalate and psychological intervention on depression accompanying with coronary heart disease. Methods 54 cases accompanied with depression were divided into two groups: the treatment group (n = 30) and control group (n = 24). The treatment group was given Escitalopram Oxalate at an initial dose of 5 mg (not more than 20 mg) a day and positive psychological intervention. The total period of treatment was 6 weeks. The control group was given conventional drugs. The effects were evaluated after 6 weeks, and adverse reactions were observed. Results After treating for 6 weeks, scores of the anxiety index, the depression index, HAMD, the situation of improved depression, the degree of decrease with Hcy, hs-CRP and clinical total efficiency of the treatment group were significantly better than those of the control group (P 0.01 or P 0.05). Conclusion Escitalopram Oxalate is effective and safe in the treatment of depression accompanying with coronary heart disease. It can be taken conveniently and has the characteristics of faster onset of action, better compliance, with fewer side effects.
[Key words] Escitalopram Oxalate; Elderly; Coronary heart disease; Depressive disorder;
文档评论(0)